Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind three-arm trial of Suhuang Zhike granules in adult post-infectious cough and cough variant asthma
CTR20250655Phase 3Active
- Sponsor
- Dongfang Yunjia
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Suhuang Zhike Granules in postinfectious cough, cough variant asthma (CVA), sponsored by Dongfang Yunjia. Started Mar 2025; status: active.
02
Drugs
Suhuang Zhike Granules
03
Conditions
postinfectious coughcough variant asthma (CVA)
Beyond the preview
Go deeper on CTR20250655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250655.